Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-24 @ 5:47 PM
NCT ID:
NCT05508568
Eligibility Criteria:
Inclusion Criteria:
* Patients who have been diagnosed with NMIBC in the previous 2 years, and are attending the urology clinic for standard of care/routine monitoring cystoscopy
* Patients 22 years of age or older
* Patients who, in the opinion of the Investigator, are suitable for standard urological investigations as part of normal clinical practice
* Patients who are, in the opinion of the Investigator, able to understand the purpose of the study and provide a full void urine specimen
* Patients who are able to give voluntary, written informed consent to participate in this study
Exclusion Criteria:
* Patients with known active (symptomatic) calculi within the urino-genitary system
* Patients who provide less than 10mL of full void urine
* Patients undergoing active treatment for interstitial cystitis
* Patients currently undergoing systemic chemotherapy or systemic immunotherapy or radiotherapy. Intravesical chemotherapy or immunotherapy (BCG) is allowed
* Patients who have previously been diagnosed with renal cancer, prostate cancer, Muscle Invasive Bladder cancer, an upper tract tumour, or CiS in the prostatic urethra
* Patients who have had urological instrumentation to the urinary tract within 14 days prior to the test
* Male patients undergoing active treatment for prostatitis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
22 Years
Study:
NCT05508568
Study Brief:
Protocol Section:
NCT05508568